tiprankstipranks
Trending News
More News >
ALK-abello A/S Class B (GB:0OIR)
:0OIR
Advertisement

ALK-abello (0OIR) Similar Shares

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ALK-abello
kr210.20
kr47.15B
46.59
16.91%
0 Buy
0 Hold
0 Sell
Moderate Buy
ALK-abello
$33.25
$7.42B
50.62
23.97%
0 Buy
0 Hold
0 Sell
Moderate Buy
Dynavax
$9.69
$1.14B
64.45
-12.78%
3 Buy
0 Hold
1 Sell
Moderate Buy
Inovio Pharmaceuticals
$2.30
$122.23M
-60.88%
4 Buy
1 Hold
0 Sell
Strong Buy
Aclaris Therapeutics
$1.91
$206.91M
64.66%
5 Buy
0 Hold
0 Sell
Strong Buy
Emergent Biosolutions
$8.21
$438.01M
3.35
35.48%
2 Buy
0 Hold
0 Sell
Moderate Buy
Novartis
$122.93
$236.75B
17.68
8.85%
1 Buy
3 Hold
1 Sell
Hold
Bristol-Myers Squibb
$45.02
$91.64B
18.17
-5.74%
4 Buy
14 Hold
1 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0OIR
ALK-abello
210.20
30.40
16.91%
AKBLF
ALK-abello
33.25
6.43
23.97%
DVAX
Dynavax
9.69
-1.42
-12.78%
INO
Inovio Pharmaceuticals
2.30
-3.58
-60.88%
ACRS
Aclaris Therapeutics
1.91
0.75
64.66%
EBS
Emergent Biosolutions
8.21
2.15
35.48%
NVS
Novartis
122.93
9.99
8.85%
BMY
Bristol-Myers Squibb
45.02
-2.74
-5.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis